YD Bio (NASDAQ:YDES) Trading Down 3.5% – What’s Next?

YD Bio Limited (NASDAQ:YDES) traded down 3.5% during trading on Tuesday . The company traded as low as $7.96 and last traded at $7.8150. 566 shares changed hands during trading, a decline of 98% from the average session volume of 36,828 shares. The stock had previously closed at $8.10.

Wall Street Analyst Weigh In

YDES has been the subject of several research analyst reports. Weiss Ratings reissued a “sell (d+)” rating on shares of YD Bio in a research report on Monday, December 29th. Wall Street Zen raised shares of YD Bio from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, YD Bio presently has an average rating of “Sell”.

YD Bio Price Performance

The company’s fifty day moving average is $9.03.

Institutional Trading of YD Bio

An institutional investor recently raised its position in YD Bio stock. Geode Capital Management LLC grew its holdings in shares of YD Bio Limited (NASDAQ:YDES) by 10.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 58,363 shares of the biotechnology company’s stock after purchasing an additional 5,292 shares during the period. Geode Capital Management LLC owned 0.08% of YD Bio worth $711,000 as of its most recent SEC filing.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.